Leukemia of Ambiguous Lineage

• CLINICAL_TRIALS trial_result · 2025-06-04
  Clinical Trial Update: Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD [Phase 2]

  Phase 2 clinical trial assessing selective depletion of CD45RA+ T cells from allogeneic stem cell grafts to prevent graft-versus-host diseas…

• CLINICAL_TRIALS trial_result · 2024-03-19
  Clinical Trial Update: Clofarabine, Idarubicin, Cytarabine, Vincristine Sulfate, and Dexamethasone in Treating Patients With Newly Diagnosed or Relapsed Mixed Phenotype Acute Leukemia [Phase 2]

  Phase 2 trial evaluating a multi-drug regimen (clofarabine, idarubicin, cytarabine, vincristine, and dexamethasone) in newly diagnosed or re…

• CLINICAL_TRIALS trial_result · 2021-11-01
  Clinical Trial Update: Higher or Lower Dose Cladribine, Cytarabine, and Mitoxantrone in Treating Medically Less Fit Patients With Newly Diagnosed Acute Myeloid Leukemia or Myeloid Neoplasm [Phase 2]

  Phase 2 trial evaluating higher or lower doses of cladribine, cytarabine, and mitoxantrone in medically less fit patients with newly diagnos…

• CLINICAL_TRIALS trial_result · 2021-10-26
  Clinical Trial Update: Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement [Phase 2]

  Phase 2 trial evaluating azacitidine with combination chemotherapy in infants with KMT2A-rearranged acute lymphoblastic leukemia and related…

• CLINICAL_TRIALS trial_result · 2021-06-30
  Clinical Trial Update: High Throughput Drug Sensitivity Assay and Genomics- Guided Treatment of Patients With Relapsed or Refractory Acute Leukemia [NA]

  Clinical trial update on high-throughput drug sensitivity assay and genomics-guided treatment for relapsed or refractory acute leukemia; stu…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.